Antagonizing STK25 Signaling Suppresses the Development of Hepatocellular Carcinoma Through Targeting Metabolic, Inflammatory, and Pro-Oncogenic Pathways

BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) is one of the most fatal and fastest-growing cancers. Recently, nonalcoholic steatohepatitis (NASH) has been recognized as a major catalyst for HCC. Thus, additional research is critically needed to identify mechanisms involved in NASH-induced he...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurhe, Yeshwant, Caputo, Mara, Cansby, Emmelie, Xia, Ying, Kumari, Sima, Anand, Sumit Kumar, Howell, Brian W., Marschall, Hanns-Ulrich, Mahlapuu, Margit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688184/
https://www.ncbi.nlm.nih.gov/pubmed/34624527
http://dx.doi.org/10.1016/j.jcmgh.2021.09.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688184/
https://www.ncbi.nlm.nih.gov/pubmed/34624527
http://dx.doi.org/10.1016/j.jcmgh.2021.09.018

Ejemplares similares